Qoolo published a Medical Micro-Content White Paper exploring how micro-content can support more relevant scientific engagement in life sciences.

Most companies start with an idea. We started with a frustration: trying to force great science onto a small screen. That frustration led us to build something that didn't exist: Qoolo, the first medical micro-content infrastructure built specifically for life sciences. Our thinking was simple: if scientific content fits in a pocket, it works in the moments it's actually needed: before a meeting, between patients, in the hallway, on the train, or on the couch after work. Qoolo gives life sciences teams a single compliant infrastructure to create, review, localize, publish, and measure medical micro-content - bringing scientific information to HCPs in the moments that matter most, while helping Commercial and Medical Affairs teams improve meeting readiness and HCP engagement. We didn't adapt a generic content platform for pharma. We built the one that we wished we had - one where compliance, references, localization, and MLR review workflows weren't features added later, but the foundation. One that could integrate with existing CRM, Digital Asset Management (DAM), and other enterprise systems - or, if you're a biotech startup building from scratch, one you can use to get structure from day one. Because content that doesn't fit the moment rarely becomes part of it. Science hasn't changed. The format has. Discover more about medical micro-content at qoolo.com.